Of note, androgen was recently shown to reduce sensitivity of AR-positive bladder cancer cells to doxorubicin [23], an anthracycline anti-tumor antibiotic often used for intravesical chemotherapy to prevent tumor recurrence. This evidence concerns the gene AR and urinary bladder carcinoma.